Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2024British Journal of HaematologyOpen Access

Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMiguel AlcocebaPSPeter StewartMGMaría García‐Álvarez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alcoceba et al. (2024) studied this question.

synapsesocial.com/papers/68e67cc7b6db643587606e00https://doi.org/10.1111/bjh.19458
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma2024 · 10 citations
  2. 2Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell Lymphoma2025 · 1 citations
  3. 3Liquid biopsy at the finish line: End-of-treatment ctDNA predicts relapse and survival in diffuse large B-cell lymphoma.2026
  4. 4Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.2025
  5. 5Integration of longitudinal ctdna MRD and PET/CT enhances prognostic stratification in newly diagnosed diffuse large B-cell lymphoma: A prospective multicenter study2025